Luís M. Ruilope

Also affiliated with Harvard University, Research Institute Hospital 12 de Octubre, Centro de Investigación en Red en Enfermedades Cardiovasculares, Hospital Universitario 12 De Octubre, Bayer (Germany), Universidad Europea de Madrid

MedicineNursing

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 14 papers. Top paper: “Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy”.

Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy

Kidney International Reports(2021)10.1016/j.ekir.2021.10.008

N/A

4.8DataRank · unranked

165 citations

Gerasimos Filippatos, Rajiv Agarwal, Stefan D. Anker, Bertram Pitt, Luís M. Ruilope +10 more

Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes

Hypertension(2022)10.1161/hypertensionaha.122.19744

N/A

2.1DataRank · unranked

98 citations

Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Peter Rossing +8 more

A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease

Clinical Kidney Journal(2022)10.1093/ckj/sfac234

N/A

2.0DataRank · unranked

102 citations

Bertram Pitt, Biff F. Palmer, Csaba P. Kövesdy, Ellen Burgess, Gerasimos Filippatos +12 more

Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results

Nephrology Dialysis Transplantation(2021)10.1093/ndt/gfab336

N/A

1.7DataRank · unranked

62 citations

Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Peter Rossing, Luís M. Ruilope +12 more

2013 ESH/ESC Guidelines for the management of arterial hypertension

European Heart Journal(2013)10.1093/eurheartj/eht151

N/A

1.4DataRank · unranked

13664 citations

Robert Fagard, Krzysztof Narkiewicz, Josep Redón, Alberto Zanchetti, Michael Böhm +86 more

2018 ESC/ESH Guidelines for the management of arterial hypertension

European Heart Journal(2018)10.1093/eurheartj/ehy339

N/A

1.4DataRank · unranked

10320 citations

Giuseppe Mancia, Wilko Spiering, Enrico Agabiti Rosei, Michel Azizi, Michel Burnier +171 more

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

European Heart Journal(2012)10.1093/eurheartj/ehs092

N/A

1.4DataRank · unranked

8514 citations

ESC Scientific Document Group, Frank Arnold Flachskampf, Z. Reiner, C. Albus, P. Benlian +123 more

Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis

European Heart Journal - Cardiovascular Pharmacotherapy(2023)10.1093/ehjcvp/pvad001

N/A

1.3DataRank · unranked

39 citations

Stefan D. Anker, Phyllis August, Andrew J.S. Coats, James L. Januzzi, Boris Mankovsky +13 more

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Diabetes Care(2022)10.2337/dc21-1944

N/A

1.2DataRank · unranked

35 citations

Ellen Burgess, Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt +92 more

Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE

Hypertension(2023)10.1161/hypertensionaha.123.21283

N/A

0.962DataRank · unranked

37 citations

Giuseppe Mancia, Roland E Schmieder, Luís M. Ruilope, Krzysztof Narkiewicz, Markus P. Schlaich +10 more

Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone

JAMA Cardiology(2023)10.1001/jamacardio.2023.1505

N/A

0.538DataRank · unranked

35 citations

Bertram Pitt, Peter Rossing, Stefan D. Anker, Gerasimos Filippatos, Luís M. Ruilope +10 more

Faculty Opinions recommendation of The Role of Podocytes and Podocyte-Associated Biomarkers in Diagnosis and Treatment of Diabetic Kidney Disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature(2020)10.3410/f.737697188.793573300

N/A

0DataRank · unranked

0 citations

Enrique Morales, Luís M. Ruilope

Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis

European Heart Journal(2021)10.1093/eurheartj/ehab777

N/A

0DataRank · unranked

1207 citations

Gerasimos Filippatos, Bertram Pitt, Stefan D. Anker, Peter Rossing, Amer Joseph +7 more

Office measurement vs. ambulatory blood pressure monitoring: associations with mortality in patients with or without diabetes

European Heart Journal(2024)10.1093/eurheartj/ehae337

N/A

0DataRank · unranked

12 citations

Alejandro de la Sierra, Felix Mahfoud, Igor Schwantke, Lucas Lauder, Bernhard Haring +7 more